These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22465904)
1. Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a randomized placebo-controlled clinical trial. Sayyah M; Olapour A; Saeedabad Ys; Yazdan Parast R; Malayeri A Nutrition; 2012 Sep; 28(9):892-5. PubMed ID: 22465904 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357 [TBL] [Abstract][Full Text] [Related]
3. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Sayyah M; Boostani H; Pakseresht S; Malayeri A Psychiatry Res; 2011 Oct; 189(3):403-6. PubMed ID: 21329988 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. Sayyah M; Boostani H; Pakseresht S; Malayeri A Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818 [TBL] [Abstract][Full Text] [Related]
15. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. Scahill L; Riddle MA; King RA; Hardin MT; Rasmusson A; Makuch RW; Leckman JF J Child Adolesc Psychopharmacol; 1997; 7(2):75-85. PubMed ID: 9334893 [TBL] [Abstract][Full Text] [Related]
16. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study. Kordon A; Wahl K; Koch N; Zurowski B; Anlauf M; Vielhaber K; Kahl KG; Broocks A; Voderholzer U; Hohagen F J Clin Psychopharmacol; 2008 Oct; 28(5):550-4. PubMed ID: 18794652 [TBL] [Abstract][Full Text] [Related]
17. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014 [TBL] [Abstract][Full Text] [Related]